Digital clinical trials could lead to new, more effective therapies

(BPT) - As the world waits for the approval and release of a COVID-19 vaccine, many are learning about the historically lengthy and arduous procedures required to conduct clinical trials.

For decades, the clinical trial process has remained largely untouched by new digital technologies, limiting the researchers and patients who could participate and slowing the development of new and effective therapies. However, as the digital revolution touches nearly every aspect of society, leveraging technology for clinical trials offers the opportunity to change the way we approach the development of new vaccines and therapies.